TMC Life Sciences BhdXKLS:0101 62 Operating Margin % is 4.27% as of Mar. 2026, which is 65% below its 10-year median of 12.37. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 666 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks better than 54.5% on this metric.
TMC Life Sciences Bhd operating margin has been in a 5-year decline. The average rate of decline per year is -22.5%.
The historical rank and industry rank for TMC Life Sciences Bhd's Operating Margin % or its related term are showing as below:
XKLS:0101'
s Operating Margin % Range Over the Past 10 Years
Min: 2.21 Med: 12.37 Max: 15.37
Current: 5.76
XKLS:0101's Operating Margin % is ranked better than 54.5% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 4.855
vs XKLS:0101: 5.76
TMC Life Sciences Bhd's 5-Year Average Operating Margin % Growth Rate was -22.50% per year.
TMC Life Sciences Bhd (XKLS:0101) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
TMC Life Sciences Bhd Operating Margin % Related Terms
TMC Life Sciences Bhd Operating Margin % Historical Data
* Premium members only.
The historical data trend for TMC Life Sciences Bhd's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0101 vs HCA, THC, DVA: Operating Margin % Comparison
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Operating Margin % distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's Operating Margin % falls into.
TMC Life Sciences Bhd Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
TMC Life Sciences Bhd's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMC Life Sciences Bhd (XKLS:0101) has a Operating Margin % of 4.27% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on TMC Life Sciences Bhd and its competitors. This is 65% below median its historical median of 12.37. Over the past decade, TMC Life Sciences Bhd's Operating Margin % has ranged from 2.21 to 15.37. According to the industry distribution chart, TMC Life Sciences Bhd ranks #303 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is TMC Life Sciences Bhd's Operating Margin % too high?
TMC Life Sciences Bhd's current Operating Margin % of 4.27% is 65% below median its 10-year median of 12.37. Over the past 10 years, this metric has ranged from a low of 2.21 to a high of 15.37. The Healthcare Providers & Services industry median Operating Margin % is 4.86. TMC Life Sciences Bhd's value of 4.27% is 12% below this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #303 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #303 out of 666 companies for Operating Margin %. This puts TMC Life Sciences Bhd in the upper half of its industry. The industry median Operating Margin % is 4.86. TMC Life Sciences Bhd's value of 4.27% is 12% below this benchmark. Historically, TMC Life Sciences Bhd's own Operating Margin % has ranged from 2.21 to 15.37 over the past decade. While the company's 10-year median is 12.37 vs. the industry median of 4.86, TMC Life Sciences Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.86, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current Operating Margin % of 4.27% is 12% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current Operating Margin % is 4.27%, which is 65% below median its own 10-year median of 12.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.45 — trading 27.4% below its estimated fair value. The current Operating Margin % is 4.27%, which is 65% below median its 10-year median of 12.37 and 12% below the Healthcare Providers & Services industry median of 4.86. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Operating Margin % is 4.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.45 is trading 27.4% below its estimated GF Value™ of RM0.62.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
Operating Margin %: 4.27% (65% below median its 10-year median of 12.37)
GF Value™: RM0.62 vs. price of RM0.45 (27.4% below fair value)
Industry Position: 12% below the Healthcare Providers & Services median (#303 of 666)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score
Get the complete analysis for XKLS:0101
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
